tirzepatide patient reviews Raleigh, N.C Mounjaro Reviews: Real Patient Ratings

Moreover, the SURMOUNT-4 clinical trial in 2024 indicated that continued once-weekly TRZ sustained weight reduction in obese patients

Clinical trials have shown that people using Tirzepatide for weight loss have seen significant reductions in body weight between 15% and 22.5% on average over 72 weeks

This is not a brand-name product

How tirzepatide compares to other GLP-1 medications by delivery method Tirzepatide is not the only GLP-1 receptor agonist available

Some people notice increased urination right as their blood sugar normalizes, followed by a gradual return to normal bathroom frequency

Tirzepatide, marketed as Mounjaro for diabetes and Zepbound for weight management, acts on the GLP-1 and GIP receptors to dramatically reduce appetite and improve metabolic function